January 2021

Eumedica is thrilled to have reached the oustanding milestone of having more than 2000 followers on LinkedIn. We want to warmly thank everyone who is engaging with our page and are looking forward to sharing more exciting news with you.

You’re not a follower yet? Here are a few reasons why you should join our community on LinkedIn:

• Be the first to hear about our new services and business opportunities;
• Find out about all congresses and other events we attend;
• Check out our job opportunities and get the chance to join our growing company.

Hopefully, we’ll count you soon as one of our followers on LinkedIn.

In order to meet constant growing demand, we are proud to announce the extension of our warehouse floor space from 7000sqm to 10000sqm. This exciting development is set to provide our customers with more GDP storage spaces and GMP rooms (labelling and packaging) for cold and ambient pharmaceutical products.

This new 3000sqm warehouse is designed to expand our activities through the following areas:

• GDP storage for pharmaceutical products at 15-25°C; 2-8°C; -20°C and -40°C
• GMP rooms for labelling and packaging at 15-25°C; 2-8°C; -20°C

“This new infrastructure is the logical continuation of former extensions and falls within our mission to ensure medical care continuity. Everyone at Eumedica is very excited by this expansion and recognise it will extend customers’ satisfaction with the same standards of services, flexibility and know-how that we have been providing for 35 years.” Virginie De Coster, Managing Director.

We are committed  to our ethos of ensuring medical care continuity and bringing vital medicines to care-givers and patients throughout the world. To this end, we have recently been approved as an AEO (Authorised Economic Operator).

What is AEO status?

The AEO is granted to companies who are involved in customs operations and international trade, and meet a range of strict criteria related to supply chain security. It shows that our business’ role in the global supply chain is secure and reliable. In other words, it seeks to create a frictionless relationship between us and customs authorities around the world, based on mutual confidence and integrity.

What are the advantages?

In the first instance, we have been awarded the Authorised Economic Operator Customs Simplification (AEOC) status. This certificate, not only recognises our reliability and stringent processes, but also allows us to benefit from:

• Easier admittance to customs simplifications     
• Priority treatment if selected for control
• Possibility to request a specific place for customs controls
• Fewer physical and document-based controls related to other customs legislation

The AEOC status is vital for our company to allow us to meet the global demands of our customers; expediting procedures to get our products to where they are needed, to help patients around the world.

Should you need more information about our services, feel free to complete the contact form.

With the Brexit transition period drawing to an end on 31st December 2020, we shall enter the new year with many rules changing on the import of goods from the EU into the UK. We have been working tirelessly to adapt to this new environment and ever striving to bridge this gap between Europe and the UK.

We are very proud to announce the launch of a new Eumedica entity: Eumedica Pharma Ltd. This new entity will enable us to overcome many of the challenges Brexit has presented all companies who rely on a European partnership, like us.

The transition period

Back in January 2020 saw the beginning of the transition period to the end of this year. We formed a new alliance with a UK distributor to store and ship medicines throughout the UK hospital network to maintain our commitment to vital medical care continuity. This guaranteed no disruption to the supply of our medicines for our customers and patients throughout this uncertain and trying period.

Our customers and the new entity

Our main priority is to limit the impact on our customers as much as possible. From the 1st January 2021 the only aspect that will change is our contact details; the team who have always managed your orders and the distributors who have delivered our medicines to you, will remain the same. Furthermore, our sales and promotion team, led by Véronique Van Ranst, Head of the UK Markets, continue to support you and will be on hand to deal with any queries you may have.

New contact details

From 1st January 2021 please use the following contact details if you contact us from the UK:

Eumedica Pharma Ltd
8 Northumberland Avenue, WC2N 5BY, London, United Kingdom
Phone +44 (0) 20 8444 3377 | Fax +44 (0) 20 8444 6866
Email : e-orders@eumedica.co.uk | Website : http://www.eumedica.co.uk
VAT : GB350 1686 15

The creation of Eumedica Pharma Ltd. is another step forward to allow us to continue providing a first-class service to our customers and ensuring medical care continuity in the UK.

For more information, please contact us now.